SS

Saksham Singla

Active Director Director DIN 10818651
DIN 10818651 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Saksham Singla

Data last updated:

Saksham Singla is a Director at Globalmed International Private Limited (since 2025) and Director at Globalmed Lifesciences Private Limited (since 2024). The companies operate in Pharma.

DIN 10818651
Primary Designation Director
Industry Pharma
First Appointment 23 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Apr 20252025Active
Director23 Oct 20242024Active

Board colleagues of Saksham Singla

Directorship timeline

Open interactive timeline →
Globalmed International Private Limited
Globalmed Lifesciences Private Limited
Premium access

Shareholding and investment profile for Saksham Singla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saksham Singla

Saksham Singla currently holds 2 directorships: Globalmed International Private Limited (Director, since 03 Apr 2025); Globalmed Lifesciences Private Limited (Director, since 23 Oct 2024).

Saksham Singla was first appointed on 23 Oct 2024 as Director at Globalmed Lifesciences Private Limited. The most recent appointment on record is 03 Apr 2025 at Globalmed International Private Limited.

The current boards of Saksham Singla's companies include Charan Kishore Singla (Globalmed International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available